Human cell lines: A promising alternative for recombinant FIX production

Protein Expression and Purification
Aline de Sousa BomfimElisa Maria de Sousa Russo

Abstract

Factor IX (FIX) is a vitamin K-dependent protein, and it has become a valuable pharmaceutical in the Hemophilia B treatment. We evaluated the potential of recombinant human FIX (rhFIX) expression in 293T and SK-Hep-1 human cell lines. SK-Hep-1-FIX cells produced higher levels of biologically active protein. The growth profile of 293T-FIX cells was not influenced by lentiviral integration number into the cellular genome. SK-Hep-1-FIX cells showed a significantly lower growth rate than SK-Hep-1 cells. γ-carboxylation process is significant to FIX biological activity, thus we performed a expression analysis of genes involved in this process. The 293T gene expression suggests that this cell line could efficiently carboxylate FIX, however only 28% of the total secreted protein is active. SK-Hep-1 cells did not express high amounts of VKORC1 and carboxylase, but this cell line secreted large amounts of active protein. Enrichment of culture medium with Ca(+2) and Mg(+2) ions did not affect positively rhFIX expression in SK-Hep-1 cells. In 293T cells, the addition of 0.5 mM Ca(+2) and 1 mM Mg(+2) resulted in higher rhFIX concentration. SK-Hep-1 cell line proved to be very effective in rhFIX production, and it can be used as a novel bio...Continue Reading

References

May 1, 1981·Archives of Biochemistry and Biophysics·G W AmphlettF J Castellino
Nov 5, 1997·Nature Biotechnology·R ZuffereyD Trono
Jun 22, 2000·Biotechnology and Bioengineering·C GeserickP P Mueller
Apr 16, 2003·The Journal of Biological Chemistry·Yasuo ShikamotoHiroshi Mizuno
Jun 28, 2003·Haemophilia : the Official Journal of the World Federation of Hemophilia·J Wight, S Paisley
Oct 29, 2005·Biotechnology and Bioengineering·Carlota Diaz Sanchez-BustamanteMartin Fussenegger
Jul 11, 2006·Protein Expression and Purification·Likui YangAlireza R Rezaie
Jul 31, 2007·Trends in Biotechnology·Susan M Browne, Mohamed Al-Rubeai
Jun 27, 2008·Biotechnology Letters·Nazanin DadehbeigiMohammad Hossein Ghahremani
Sep 18, 2010·The Journal of Gene Medicine·Inge PetrusThierry VandenDriessche
Jan 6, 2011·British Journal of Clinical Pharmacology·Massimo Franchini, Pier Mannuccio Mannucci
Feb 24, 2011·Xenotransplantation·Vered Padler-Karavani, Ajit Varki
Aug 16, 2011·Biotechnology and Applied Biochemistry·Andrielle de Castilho FernandesDimas Covas
Nov 23, 2013·Protein and Peptide Letters·Virgínia Picanco-CastroKamilla Swiech
Dec 18, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·L A ValentinoS Knaub
May 17, 2014·Expert Review of Hematology·Jerzy WindygaAndrea E Hafeman

❮ Previous
Next ❯

Citations

Mar 10, 2017·Bioengineered·Kamilla SwiechDimas Tadeu Covas
Nov 2, 2020·Biotechnology Letters·Aline Sousa BomfimElisa Maria Sousa Russo
Mar 4, 2021·Blood Advances·Benjamin J Samelson-JonesValder R Arruda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.